Radioisotopic detection of sentinel lymph nodes in clinically localized high-risk prostate cancer

被引:0
|
作者
Hinev, A. [1 ]
Klissarova, A. [2 ]
Ghenev, P. [3 ]
Kolev, N.
Chaushev, B. [2 ]
Chankov, P. [1 ]
Anakievski, D. [1 ]
Dyakov, S. [1 ]
Stratev, S.
Deliisky, T. [4 ]
机构
[1] St Marina Univ Hosp, Clin Surg 3, Div Urol, Varna, Bulgaria
[2] St Marina Univ Hosp, Dept Radiol, Varna, Bulgaria
[3] St Marina Univ Hosp, Dept Pathol, Varna, Bulgaria
[4] G Stranski Univ Hosp, Dept Surg Oncol, Pleven, Bulgaria
来源
JOURNAL OF BUON | 2009年 / 14卷 / 04期
关键词
gamma probe; lymph node dissection; lymphoscintigraphy; prostate cancer; sentinel lymph node; PELVIC LYMPHADENECTOMY; RADICAL PROSTATECTOMY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To explore the efficacy of a radioisotopic (RI) method in detecting sentinel lymph nodes (SLNs), known as sites of harboring metastases, in localized high-risk prostate cancer (HRPC). Methods: The RI method was applied to 26 males with clinically localized HRPC, subjected to radical prostatectomy in 2006-2008. All had poor pathological characteristics: initial PSA > 15 ng/ml, Gleason score > 7, clinically suspected extracapsular extension, seminal vesicle invasion, and/or positive pelvic lymph nodes (LNs). The radiopharmaceutical (Tc-99m) was injected preoperatively at 4 zones of the periphery of the prostate. Tc-99m-nanocolloid particles were <= 80 nm in size, with total activity of 3 mCi (111 MBq), diluted in 2 mL. One hour after Tc-99m administration, a planar scintigraphy was performed on a gamma camera in anterior posterior and lateral projections. A high resolution collimator was used, gathering impulses up to 300 000 per frame. The precise location of the SLNs was determined intraoperatively by a gamma probe. The LNs removed by extended pelvic lymphadenectomy were arranged on an anatomical template, examined ex vivo by the gamma probe and scanned again. The LNs were cleaned from the adjacent fatty tissue, fixed in neutral formalin, and then processed separately for histological and immunohistochemical examination. Results: The number of surgically removed LNs ranged from 9 to 38 (mean 13), and the SLAs from 1 to 7 (mean 3). The SLNs were visualized on lymphoscintigraphy as strictly defined, round zones of high activity and were easily recognized intraoperatively by the gamma probe. The scintigraphic images of the scanned anatomical templates correlated well with those prior to surgery. Histology confirmed LN metastases in 11 cases. 94% of the metastatic LNs were SLNs, accurately detected by the RI method. Only 2 metastatic LNs showed no activity prior to, and during the operation. Most of the metastatic LNs (62%) were SLNs, located out of the obturator fossa. Conclusion: The radioisotopic detection of the SLNs in HRPC is an objective and sensitive method that aids the surgeon to take a proper decision regarding the scope of the pelvic LN dissection in each particular case.
引用
收藏
页码:661 / 667
页数:7
相关论文
共 50 条
  • [21] Detection of Sentinel Lymph Nodes in Gastric Cancer
    Chernov, V. I.
    Sinilkin, I. G.
    Avgustinovich, A. V.
    Afonasyev, S. G.
    Titskaya, A. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S232 - S232
  • [22] Chemotherapy and novel therapeutics before radical prostatectomy for high-risk clinically localized prostate cancer
    Cha, Eugene K.
    Eastham, James A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (05) : 217 - 225
  • [23] Radical prostatectomy in clinically localized high-risk prostate cancer: Outcome of 231 consecutive patients
    Roder, Martin Andreas
    Berg, Kasper Drimer
    Christensen, Ib Jarle
    Gruschy, Lisa
    Brasso, Klaus
    Iversen, Peter
    SCANDINAVIAN JOURNAL OF UROLOGY, 2013, 47 (01) : 19 - 25
  • [24] Detection and Phenotyping of Circulating Tumor Cells in High-Risk Localized Prostate Cancer
    Pal, Sumanta K.
    He, Miaoling
    Wilson, Timothy
    Liu, Xueli
    Zhang, Keqiang
    Carmichael, Courtney
    Torres, Alejandra
    Hernandez, Sonya
    Lau, Clayton
    Agarwal, Neeraj
    Kawachi, Mark
    Yen, Yun
    Jones, Jeremy O.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (02) : 130 - 136
  • [25] Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer
    Ferrari, AC
    Stone, NN
    Eyler, JN
    Gao, M
    Mandeli, J
    Unger, P
    Gallagher, RE
    Stock, R
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (20) : 1498 - 1504
  • [26] Contemporary treatment of high-risk localized prostate cancer
    Tareen, Basir
    Kimmel, Joseph
    Huang, William C.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (07) : 1069 - 1076
  • [27] Immunosuppressive milieu of high-risk localized prostate cancer
    Ricardo, Victor
    Febles, Adorno
    Adeegbe, Dennis
    Ahsan, Aarif
    Wu, Jiansheng
    Khodadad-Jamayran, Alireza
    Lepor, Herbert
    Wysock, James
    Taneja, Samir
    Huang, William C.
    Balar, Arjun Vasant
    Melamed, Jonathan
    Deng, Fang-Ming
    Ren, Qinghu
    Tsirigos, Aristotelis
    Kufe, Donald W.
    Heguy, Adriana
    Wong, Kwok-Kin
    Wise, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [28] Lymph node staging in clinically localized prostate cancer
    Wawroschek, F
    Hamm, M
    Weckermann, D
    Vogt, H
    Harzmann, R
    UROLOGIA INTERNATIONALIS, 2003, 71 (02) : 129 - 135
  • [29] Role of surgery in high-risk localized prostate cancer
    Lawrentschuk, N.
    Trottier, G.
    Kuk, C.
    Zlotta, A. R.
    CURRENT ONCOLOGY, 2010, 17 : S25 - S32
  • [30] Localized intermediate- to high-risk prostate cancer
    Tritschler, S.
    Ganswindt, U.
    Stief, C. G.
    UROLOGE, 2016, 55 (03): : 318 - +